“PsA rarely presents de novo; it usually evolves after a 3- to 10-year subclinical interval following cutaneous [psoriasis],” ...

This FAQ covers the current prior authorization landscape, what's coming, and what health care stakeholders can expect. Q: ...

For Xavier Leleu, MD, PhD, there is opportunity to ensure that therapeutic advances are accompanied by advances in how those therapies are delivered. The treatment landscape for multiple myeloma (MM) ...

Respiratory therapists are another essential building block of a comprehensive care team for patients with bronchiectasis, said Robert A. Balk, MD, professor emeritus in the Department of Internal ...

“ACO-SWITCH is a prospective study in adults with ATTR-CM,” wrote the researchers. “The study will determine the effects of ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs. Medicare Part D plans are running out of easy ways to absorb the cost ...

One in 5 adults with newly diagnosed moderate to severe plaque psoriasis maintained clear or almost-clear skin a full year ...